Newsletter · · Ashutosh Agarwal

Vice & Wellness - Alcohol & Nicotine - Week of June 24, 2026: Jefferies Says Beer's Slump Is a Cycle, Near Bottom

Vice & Wellness (alcohol & nicotine) newsletter for the week of June 24, 2026. Jefferies' beverages analyst calls the beer slowdown cyclical and near its end, the value war recruits first-time buyers, and Evercore's calorie-deflation data keeps the structural-moderation bears in the argument.

Vice & Wellness: Alcohol & Nicotine

Week of June 24, 2026: Jefferies Says Beer's Slump Is a Cycle, Near Bottom

The loudest voice on the tape this week wasn't a bear on beer. It was a sell-side analyst standing in front of the "drinking is dying" narrative and saying, flatly, that it's a cycle and we're past the worst of it. Pair that with a value-war launch pulling first-time buyers into the category and a calorie-deflation print that says the moderation story is real too, and you get the central tension of the moment: the data supports both sides, but this week the people who actually move product sounded like buyers, not sellers.

TL;DR

  • Jefferies' Kaumil Gajrawala calls the beer slowdown "absolutely a cycle" and says we're near the end of it: Hispanic/Constellation consumer recovering, GLP-1 impact overstated, Molson Coors guidance "probably too high" on execution gaps.
  • The value war is adding drinkers, not stealing them: Bush Light Apple did 2.5M cases in six weeks, 70% incremental, one in four buyers brand-new to beer.
  • Nicotine reduced-risk stayed off the tape: no notable Zyn, on!, Velo, heated-tobacco, or FDA-enforcement developments worth flagging on the pods this week.

What's new

Jefferies plants a flag: it's a cycle, not a funeral. On Beernet Radio (Ep. 338, June 18), Jefferies beverages MD Kaumil Gajrawala was unambiguous: "It's a cycle. It's absolutely a cycle… we're probably towards the end of the cycle." His mechanism is affordability, not abstinence: the share of people citing cost as a reason not to drink "doubled from 2021," and he sees wage growth and employment pulling the core consumer back. This is a named analyst making a tradeable, contrarian call against the structural-decline consensus.

The value war is genuinely expanding the pie. Distributor insiders on Tapped In (Ep. 114, June 23) put hard numbers on AB InBev's (BUD) flavored-value push: Bush Light Apple/Capple sold "two and a half million cases… in the six weeks of scans," with "one in four… first-time beer buyers. And 70% of the sales are incremental to the category." Keystone Light Apple relaunches in the fall. This is the cleanest demand-addition data point of the week: the value segment isn't cannibalizing, it's recruiting.

Molson Coors (TAP): the bull case is self-inflicted. Gajrawala flagged the oddity that TAP can be "out-of-stocks and down 5% in volumes" simultaneously, the residue of 15 years of cost-cut-and-reorg cycles. His prescription is to spend: "their medium-term guidance is probably too high… they should spend more below it to solve on some of that execution." Jefferies trimmed its price target post-survey. The setup, High Life as a potential Bush Light analog under a new CEO, is real, but it requires investment the Street isn't yet sure management will make.

Evercore quantifies the other side: alcohol calories are falling "tremendously." On The Real Eisman Playbook (Ep. 65, June 22), three Evercore analysts said U.S. calorie consumption is "down 2%… year over year," and "a lot of it's due to alcohol. Alcohol has declined tremendously." They peg GLP-1 as only a ~half-point headwind to food, implying alcohol is eating a disproportionate share of the cut. Held against Gajrawala's skepticism, you get the real debate in one frame.

The GLP-1 mechanism on drinking is now settled science, but bounded. A medical expert on Double Take by BNY Investments Newton (June 17) confirmed the receptors that govern craving sit in the central nervous system, and "the literature is now suggesting helpful with alcohol… the cravings that come with addiction seem to be dampened." The caveat that matters for your model: effects are strongest on pathological, not casual, consumption, so the population-level hit is real but capped.

The debate

This week the tape leaned hard on the bear-of-the-bull view, i.e., the people closest to the product think the alcohol decline is cyclical and overstated.

Bull (structural decline is permanent): The strongest support came from outside the beer aisle. Evercore's calorie-deflation data and the BNY medical confirmation that GLP-1 genuinely attenuates alcohol craving give the generational-moderation thesis empirical teeth. If GLP-1 adoption compounds and Gen Z participation stays depressed, the "it's a cycle" crowd is fighting demographics.

Bear (the dip is cyclical and offset): This is where the operators live this week. Gajrawala's affordability framing, the Hispanic-consumer recovery, oil down ~26% to the mid-$70s (a high-correlation tailwind to lower-income alcohol consumption, per the Tapped In distributors), the World Cup on-premise activation, and the value war pulling in new buyers all point to a demand trough that's lifting. Even the THC distributor on BrandBuilders (Ep. 461, June 18) sees a "bounce back" in the 21–25 cohort.

On nicotine, the bull/bear smoke-free debate did not get a voice on the pods this week, no operator, analyst, or pundit touched reduced-risk volumes, pricing, or regulation. Worth a flag given how chatty that space usually is.

Read-throughs

  • Non-alc beer (Athletic Brewing / KDP): CEO Bill Shufelt on the Brewbound Podcast (June 17) pegged Athletic at "18% to 22% of the category" and "50% of craft non-alcoholic beer," yet still in only "10%" of independent retailers and "really not there yet" in c-store, where "50-plus percent of beer sales" happen. The runway is a distribution unlock, not a demand question. His sharpest warning: celebrity NA brands over-indexing on sobriety messaging risk pushing the 80%+ of NA drinkers who still drink alcohol "into non-consideration."
  • Non-alc cocktails / "mainstream moderator": Dirty Virgo's co-founder on Healthy Hustle Spotlight (June 23) frames non-alc as "a complement, not a replacement" in a "$400 billion market," and explains why incumbents like BUD structurally can't incubate it: a $50M brand "isn't even point whatever percent of just one year's growth." Read: this category gets bought, not built.
  • THC beverages: Two independent channel sources flagged THC taking cold-vault and end-cap space from beer/RTDs, Total Wine "an entire shelf," plus the Bump Williams Consulting president on At Your Convenience (June 23). The catalyst to diary: a November legal sunset that could strand inventory if the window closes, or accelerate substitution if it's codified.
  • Functional beverages & input costs: Joshua Schall's aluminum-crisis episode (June 23), LME aluminum above $3,700/ton, argues traditional canned beer/RTD brands face worse margin compression than functional brands with "form factor agility" and higher price-per-ounce. A quiet headwind for the canned-alcohol complex.

What changed

The narrative pendulum swung toward "cyclical" this week. Two weeks of "Gen Z killed drinking" headlines met a named Jefferies analyst, a fresh distributor survey, hard value-war scan data, and a falling oil price, and the operator consensus came out the other side. The structural bears still have the GLP-1 and calorie data; they just didn't have the microphone this week.